Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | -0.57% |
|
-1.13% | -22.45% |
03/06 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
03/06 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.45% | 255M | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.47% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.94% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- Earnings Flash (QURE) UNIQURE Posts Q2 Revenue $2.4M